Yoshiko Murakata
Musashimurayama, 2080011, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model.
Journal: International journal of molecular sciences
Published: September 12, 2025
Cytokine profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study.
Journal: Molecular biology reports
Published: July 03, 2025
4E-BP3 deficiency impairs dendritic cell activation and CD4+ T cell differentiation and attenuates α-myosin-specific T cell-mediated myocarditis in mice.
Journal: Basic research in cardiology
Published: May 31, 2024
An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 15, 2024
Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
Journal: Scientific reports
Published: October 21, 2023
Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy.
Journal: Frontiers in cardiovascular medicine
Published: October 20, 2022
Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.
Journal: Clinical science (London, England : 1979)
Published: May 16, 2022
A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: March 14, 2022
Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
Journal: Frontiers in pharmacology
Published: February 27, 2022
Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
Journal: Life sciences
Published: February 08, 2022
Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
Journal: Clinical science (London, England : 1979)
Published: April 23, 2021
Last Updated: 09/26/2026